© Copyright 2015 Clinical Research Strategies. All Rights Reserved.

LIFE SCIENCE EXECUTIVE

Do you have the right strategies and resources to attract investors and successfully bring a new product to market in a realistic period of time?

For most Class I and Class II products, receiving regulatory approval is considered a fairly easy road.  However, without solid pre-study documentation/testing,  well-designed post-market studies, and regulatory conformance plans, challenges to gain market adoption can arise.  For novel Class II or Class III products with risks, including where there is no predicate or equivalent product, the road is full of pitfalls and distractions. Your company’s success will depend upon the expertise of your talent and the solid yet flexible strategic planning and execution of its clinical trials, regulatory pathway, reimbursement initiatives, and product commercialization efforts. Moreover, it is essential to discover what you don’t know and to keep apprised of the ever-changing regulatory environment to clearly convey the investments you need. 

Clinical Research Strategies can help you rapidly advance your understanding of the entire clinical trials lifecycle paradigm to analyze the best approaches that strike a balance between:

  • regulatory requirements
  • trial planning, efficiency, and operations
  • clinical trial sites and investigators
  • patient recruitment and enrollment rates
  • proper engagement with key opinion leaders and investigators
  • fair market value rates
  • ethical considerations
  • meaningful clinical endpoints for labeling claims, market adoption, and reimbursement
  • expectations of all stakeholders
  • risk management
  • realistic costs and timetable projections
  • resourcing decisions